Details for New Drug Application (NDA): 087907
✉ Email this page to a colleague
NDA 087907 describes EPINEPHRINE, which is a drug marketed by Armstrong Pharms, Am Regent, Bpi Labs, Intl Medication Sys, Hospira, and Teva Pharms Usa, and is included in eight NDAs. It is available from nine suppliers. There are three patents protecting this drug. Additional details are available on the EPINEPHRINE profile page.
The generic ingredient in EPINEPHRINE is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
The generic ingredient in EPINEPHRINE is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 087907
| Tradename: | EPINEPHRINE |
| Applicant: | Armstrong Pharms |
| Ingredient: | epinephrine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087907
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.2MG/INH | ||||
| Approval Date: | May 23, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
